Vanguard Group Inc Xencor Inc Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Xencor Inc stock. As of the latest transaction made, Vanguard Group Inc holds 8,624,374 shares of XNCR stock, worth $66.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,624,374
Previous 7,898,466
9.19%
Holding current value
$66.8 Million
Previous $84 Million
19.34%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding XNCR
# of Institutions
203Shares Held
81.7MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY11.1MShares$86 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA10.5MShares$81.6 Million0.07% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.14MShares$47.6 Million4.16% of portfolio
-
State Street Corp Boston, MA3.82MShares$29.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.76MShares$29.1 Million0.0% of portfolio
About Xencor Inc
- Ticker XNCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,698,100
- Market Cap $463M
- Description
- Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...